Both total and phosphorylated tau are increased in Alzheimer's disease. - Wikidata - wikimedia - TriplyDB

Both total and phosphorylated tau are increased in Alzheimer's disease.

Both total and phosphorylated tau are increased in Alzheimer's disease.

http://www.wikidata.org/entity/Q41765446

about

Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studies Biomarkers in dementia: clinical utility and new directions Tau Biology and Tau-Directed Therapies for Alzheimer's Disease Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression MRI and CSF studies in the early diagnosis of Alzheimer's disease.CSF biomarkers for mild cognitive impairment.Alzheimer's Disease Cerebrospinal Fluid and Neuroimaging Biomarkers: Diagnostic Accuracy and Relationship to Drug Efficacy.Imaging and CSF studies in the preclinical diagnosis of Alzheimer's disease.Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review.Fibrinogen gamma-A chain precursor in CSF: a candidate biomarker for Alzheimer's disease Immunological memory to hyperphosphorylated tau in asymptomatic individuals.Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.Total and phosphorylated tau protein as biological markers of Alzheimer's disease.The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob disease Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.A Pilot Longitudinal Study on Cerebrospinal Fluid (CSF) Tau Protein in Alzheimer's Disease and Vascular Dementia.Neuroproteomics as a promising tool in Parkinson's disease research.Biomarkers for cognitive impairment in Parkinson disease.Decreased level of olfactory receptors in blood cells following traumatic brain injury and potential association with tauopathy Brain atrophy in healthy aging is related to CSF levels of Aβ1-42.Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.Cerebrospinal fluid brain-derived proteins in the diagnosis of Alzheimer's disease and Creutzfeldt-Jakob disease.Emerging biomarkers in cognition.Characterization of novel CSF Tau and ptau biomarkers for Alzheimer's disease.Expression of Tau40 induces activation of cultured rat microglial cells.Does CSF p-tau181 help to discriminate Alzheimer's disease from other dementias and mild cognitive impairment? A meta-analysis of the literature.CSF tau and β-amyloid as biomarkers for mild cognitive impairment.Increased intrathecal inflammatory activity in frontotemporal dementia: pathophysiological implications Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble.CSF markers for Alzheimer's disease: total tau, phospho-tau and Abeta42.Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients : an ultrasensitive bienzyme-substrate-recycle enzyme-linked immunosorbent assay.Cerebrospinal fluid protein biomarkers for Alzheimer's disease.Cerebrospinal Fluid Biomarkers for the Differential Diagnosis between Alzheimer's Disease and Frontotemporal Lobar Degeneration: Systematic Review, HSROC Analysis, and Confounding Factors.CSF biomarkers for Alzheimer's disease: use in early diagnosis and evaluation of drug treatment.Changes of Cerebrospinal Fluid Peptides due to Tauopathy.Neurochemical biomarkers in Alzheimer's disease and related disorders.Cerebrospinal fluid tau, A beta, and phosphorylated tau protein for the diagnosis of Alzheimer's disease.Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease.Cerebrospinal fluid and neuroimaging biomarker abnormalities suggest early neurological injury in a subset of individuals during primary HIV infection.Cerebrospinal Fluid Biomarkers of Simian Immunodeficiency Virus Encephalitis : CSF Biomarkers of SIV Encephalitis.

P2860

Q26798325-F4CE99B1-FB7E-47F0-A698-BD49951F9F2B Q27007086-92DFB23A-4C5E-465E-99E2-35B4EB27E1F5 Q28071398-A76BA6FC-B4B7-499C-9D80-9921455282C4 Q30501271-2E39FAAE-9975-49D5-9448-3D59803BFC72 Q30953178-691CDEA4-D71B-4FF4-88A7-DBAB59509256 Q30953185-40296405-9DC3-4398-8E35-55CD995BE3DC Q30996799-D290B855-1C3F-4936-87F1-C1BFF30910FF Q31108280-A39BE1C0-465C-4D83-9DF9-F69A7B2600CC Q31146512-E08509E0-1FBC-4E94-A4A7-44EC279AD0FF Q33287487-3AC1FC75-29CF-4A65-A65D-BB40DB3CE01A Q33559360-F3FDFCBF-D925-4351-8CCB-E82D72A30E3A Q33590723-93817818-56AF-424B-A483-76674AE82614 Q33624674-FC8C9423-680A-49E7-8CF4-1802B3AAC4A3 Q33649832-308F3D08-8D98-4562-843A-21C292508141 Q33666765-4E2937B7-3345-4BA2-8F5F-61F00C8997E0 Q33695805-F5F53928-4A0A-48AF-BC56-5AA126AA3426 Q33821316-051788F4-06A5-41A8-B0CB-DE01568F4F09 Q33896664-0D777527-07B3-47F1-B29A-6CE028C128F9 Q34317749-E9DD4A98-C20E-4D4C-A47C-952FB3206364 Q34514638-1394CD47-A777-4370-832C-DC06AA17FF72 Q34776835-25811B7A-E7B3-4DB6-BC3C-30DA7AC09DE1 Q35005803-52183A12-799D-4F43-9BE8-DEF976E91E2B Q35008258-FD0B4485-ECF0-49E5-A89D-D1C0A2F61A01 Q35014708-F80A8AAC-B0D7-40E4-AF45-9F4A85F0AFD1 Q35022620-0D84D1AD-3C71-49EC-BBDE-7816197E038B Q35166684-CD88CB2D-7188-4058-A7BB-77644CE6FE80 Q35236838-F460DCB6-74EF-4CBA-B433-06DF2D5D2E09 Q35482194-5FD3D917-6CC2-467F-89B7-000AB5C4BB01 Q35576517-8730228E-1289-4C21-A204-0B55A4920040 Q35580179-CE6F8BDA-A5EB-460B-8B6A-92584CD39121 Q35788903-F8B61C6E-C8BD-46C2-A039-5CEF67D4FCBC Q36045282-28AC7BFA-319E-471B-87AD-70338DEA84D9 Q36157458-DA13F496-CAC0-453B-802A-1635E2615E15 Q36252166-E68235A2-ADFD-4433-BF5F-7D16B6BAB7FE Q36357894-B772E8F9-41C4-4627-A0B7-E69E8BA8B74F Q36366891-974072CD-8F29-41FC-BD27-1E1FBA9F6157 Q36382217-29173B59-F64B-447C-9817-8F182A7227A5 Q36626657-8120BED9-5E11-4C2C-ADFB-10D33BAD5227 Q36796560-282C2BE3-2AF6-4279-B875-6B33DD780A7C Q36913222-A1F429D3-1C90-45DF-A32A-8E5C63996EE2

P2860

Both total and phosphorylated tau are increased in Alzheimer's disease.

http://www.wikidata.org/entity/Q41765446

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

2001年论文

@zh

2001年论文

@zh-cn

name

Both total and phosphorylated tau are increased in Alzheimer's disease.

@en

type

label

Both total and phosphorylated tau are increased in Alzheimer's disease.

@en

prefLabel

Both total and phosphorylated tau are increased in Alzheimer's disease.

@en

P1433

Q41765446-93069FA9-55E8-4811-A14B-C0E29C0191DF

P1476

Q41765446-60928850-8E35-46BC-A5EE-C5C7D836FB37

P2093

Q41765446-280B052F-E5FD-4858-87F7-88765897BE96

Q41765446-3686B848-12F1-4367-9AEB-64C379D06572

Q41765446-3CE761F6-2D0B-4A3B-B452-C291820BDE88

Q41765446-9ABB1DB9-F47E-4F2D-A04E-327498C4F5EE

Q41765446-AF323F06-6277-463E-9D7E-E61F4DF1FC79

Q41765446-FDE96A32-B332-4CF6-B105-3D677B61B2AB

P2860

Q41765446-0A958899-3905-4AE6-A864-42E9370DB2D3

Q41765446-0BF483F0-0787-49B3-B6BB-32955E1693EA

Q41765446-12E86FE2-DF36-4281-9E4E-DC1318C65A4D

Q41765446-13E39B10-7262-44AF-9F75-6DC596C19B94

Q41765446-2A74E752-8572-434A-B458-99A5FE00E588

Q41765446-2D50CD41-EB1F-4CF0-B9F1-7353CAFDA6F1

Q41765446-32CE3B6E-012C-40F5-96D3-06C3EE541670

Q41765446-3B046FB5-4D6C-4302-9DBC-C4574C2BF4B0

Q41765446-3CF1C60D-F4CD-47F1-809E-261AE4B1BADD

Q41765446-4123A480-0E4C-4EBA-8C05-5BD022DCC57B

P304

Q41765446-CEDB11C0-44F0-4ABC-9537-D350740571CF

P31

Q41765446-50C829E8-F2A2-4341-BB6B-3439153FDC38

P356

Q41765446-CF7F7842-2687-4B89-AF8C-B580B2089DC4

P407

Q41765446-68EE2D0A-C7C7-426E-88F5-6C78FA50B78A

P433

Q41765446-76913078-8515-4247-B120-23536B24B3F1

P478

Q41765446-93CE6CB8-0126-4027-90F2-E54D303C4315

P50

Q41765446-3830F001-A73B-4EBD-8DA4-EFB331F00BF4

Q41765446-4A6882A8-DFDB-4C24-94CD-ADBA238528EF

Q41765446-70E3EBFB-A378-4C2C-9A1F-1D4733A67B8A

Q41765446-77FDABAB-FB0E-4831-BD63-7D4C61FB5E33

P577

Q41765446-F33409C4-1119-4FB4-927C-7EF581DE01F6

P5875

Q41765446-06D0868D-3E31-4CE8-9B6F-2C114461C97D

P698

Q41765446-30BFD19E-530D-48B8-890B-32D3CB607789

P921

Q41765446-01580302-758E-45D3-8BE1-631D1593A529

Q41765446-7CA2E65A-5A8E-4CFB-B93B-B043D35C72C5

P932

Q41765446-D11B2E4B-9315-4A0D-AEDD-A24240A2842A

P356

P1433

Journal of Neurology, Neurosurgery and Psychiatry

P1476

Both total and phosphorylated tau are increased in Alzheimer's disease.

@en

P2093

Davidsson P

http://www.w3.org/2001/XMLSchema#string

Granérus AK

http://www.w3.org/2001/XMLSchema#string

Tullberg M

http://www.w3.org/2001/XMLSchema#string

Vanderstichele H

http://www.w3.org/2001/XMLSchema#string

Wallin A

http://www.w3.org/2001/XMLSchema#string

Wikkelso C

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau

“Mini-mental state”

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

Characterization of proteins from human cerebrospinal fluid by a combination of preparative two-dimensional liquid-phase electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

CSF sulfatide distinguishes between normal pressure hydrocephalus and subcortical arteriosclerotic encephalopathy

The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development.

Measurement of distinct immunochemical presentations of tau protein in Alzheimer disease.

Rapid and sensitive colorimetric method for visualizing biotin-labeled DNA probes hybridized to DNA or RNA immobilized on nitrocellulose: Bio-blots.

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

P304

624-630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/JNNP.70.5.624

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P50

Eugeen Vanmechelen

Magnus Sjögren

Lennart Minthon

P577

2001-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12026054

http://www.w3.org/2001/XMLSchema#string

P698

11309456

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

phosphorylation

P932

1737352

http://www.w3.org/2001/XMLSchema#string